Intra Cellular Therapies shares owned by Vanguard Group
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $1.3B | 9.5M | 131.92 |
| 2024-12-31 | $812M | 9.7M | 83.52 |
| 2024-09-30 | $705M | 9.6M | 73.17 |
| 2024-06-30 | $658M | 9.6M | 68.49 |
| 2024-03-31 | $638M | 9.2M | 69.20 |
| 2023-12-31 | $651M | 9.1M | 71.62 |
| 2023-09-30 | $445M | 8.5M | 52.09 |
| 2023-06-30 | $538M | 8.5M | 63.32 |
| 2023-03-31 | $457M | 8.4M | 54.15 |
| 2022-12-31 | $440M | 8.3M | 52.92 |
| 2022-06-30 | $461M | 8.1M | 57.08 |
| 2022-03-31 | $477M | 7.8M | 61.19 |
| 2021-09-30 | $257M | 6.9M | 37.28 |
| 2021-06-30 | $279M | 6.8M | 40.82 |
| 2021-03-31 | $228M | 6.7M | 33.93 |
| 2020-12-31 | $206M | 6.5M | 31.80 |
| 2020-09-30 | $160M | 6.2M | 25.66 |
| 2020-06-30 | $135M | 5.3M | 25.66 |
| 2020-03-31 | $81M | 5.3M | 15.37 |
| 2019-12-31 | $145M | 4.2M | 34.31 |
| 2019-09-30 | $31M | 4.2M | 7.46 |
| 2019-03-31 | $51M | 4.2M | 12.18 |
| 2018-12-31 | $45M | 3.9M | 11.31 |
| 2018-09-30 | $86M | 3.9M | 21.71 |
| 2018-06-30 | $69M | 3.9M | 17.68 |
| 2018-03-31 | $79M | 3.7M | 21.05 |
| 2017-12-31 | $54M | 3.7M | 14.48 |
| 2017-09-30 | $55M | 3.5M | 15.83 |
| 2017-06-30 | $34M | 2.7M | 12.42 |
| 2017-03-31 | $45M | 2.7M | 16.25 |
| 2016-12-31 | $39M | 2.6M | 15.11 |
| 2016-09-30 | $38M | 2.5M | 15.24 |
| 2016-06-30 | $91M | 2.4M | 38.82 |
| 2015-12-31 | $75M | 1.4M | 53.80 |
| 2015-09-30 | $39M | 961k | 40.04 |
| 2015-06-30 | $23M | 724k | 31.94 |
| 2015-03-31 | $15M | 630k | 23.88 |
| 2014-12-31 | $7.9M | 449k | 17.64 |
| 2014-09-30 | $5.6M | 405k | 13.71 |
| 2014-06-30 | $6.7M | 395k | 16.85 |
| 2014-03-31 | $6.2M | 338k | 18.22 |
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies